登录

[Exclusive] Miao Shou Doctor Completed Series C Financing

作者: Mailman 2019-06-27 18:04
圆心科技
https://www.yuanxinjituan.com/
企业数据由 动脉橙 提供支持
互联网医疗服务提供商 | F轮 | 运营中
中国-北京
2021-08-03
融资金额:RMB¥15亿
红杉资本中国基金
查看

According to VCBeat, Miao Shou Doctor just finished Series C financing. This round of financing was led by Starquest Capital and followed by Sequoia Capital. After this round of financing, Miao Shou Doctor's market value would exceed 7 billion RMB.

 

Miao Shou Doctor's chain pharmacy has established more than 200 direct pharmacies in 23 provinces and 66 cities across the country. Right now, Miao Shou Doctor is selling more than 26,000 kinds of medicines including around 300 cancer-targeting drugs. The company's Miao Shou online hospital provides online diagnosis and health management services through live broadcasts, short videos, and articles.

 

This online platform can also help the government to track all prescription drug sales and also helping people in the rural areas to get the best medicines. Miao Shou Doctor is also working with insurance companies to reduce the purchase price for their medicines. These methods could create a seamless experience for all patients.


>>>>

About Starquest Capital


Starquest Capital is a leading private equity institution focusing on New Economy through direct investment and FOF investment.


>>>>

About Sequoia Capital


Sequoia Capital is an investment company in China that focuses on media, health care and technology startups. 

文章标签 互联网医院
注:文中如果涉及企业数据,均由受访者向分析师提供并确认。
声明:动脉网所刊载内容之知识产权为动脉网及相关权利人专属所有或持有。转载请联系tg@vcbeat.net。

Mailman

医疗行业观察者

分享
动脉橙
以上数据来自动脉橙产业智库

我们以独创的在线数据库方式,为健康产业人士提供全方位和实时的市场资讯、行业数据和分析师见解。现已覆盖数字健康、医疗器械、生物医药等近500+细分赛道,涉及公司名单、招投标、投融资信息、头部企业动态等各类数据并持续更新。

点击 【申请试用】了解动脉橙产业智库更多内容。
精彩内容推荐

破解“医疗不可能三角”,天津数字健共体开出三张“创新处方”

龙岩数字健共体取得新进展,微医龙岩互联网医院打通在线医保支付

程书钧、刘力生出任首席顾问专家,医联为何要成立学术委员会?

数字医疗服务引领产业新赛道,微医亮相亚布力青年论坛第六届创新年会

Mailman

共发表文章3245篇

最近内容
  • 知之甚少:调研885名投资人后,原来美国VC们这样做决策

    2023-03-20

  • 辉瑞想要收购Seagen只是开始,这才是2023年并购的两大趋势

    2023-03-05

  • 【融资】核药企业Ratio再融资2000万美元,和拜耳合作研究新前列腺癌放射性疗法

    2023-02-09

上一篇

TissueTech完成8200万美元C轮融资,研发冻存羊膜技术助力眼部组织再生

2019-06-27
下一篇

中国医师执业信用评价标准正式启动,大数据助力中国医师执业信用体系建设

2019-06-27